Breast Cancer Research and Treatment

, Volume 136, Issue 3, pp 859–868 | Cite as

Pattern of follow-up care and early relapse detection in breast cancer patients

  • Sandra M. E. Geurts
  • Femmie de Vegt
  • Sabine Siesling
  • Karin Flobbe
  • Katja K. H. Aben
  • Margriet van der Heiden-van der Loo
  • André L. M. Verbeek
  • Jos A. A. M. van Dijck
  • Vivianne C. G. Tjan-Heijnen
Epidemiology

Abstract

Routine breast cancer follow-up aims at detecting second primary breast cancers and loco regional recurrences preclinically. We studied breast cancer follow-up practice and mode of relapse detection during the first 5 years of follow-up to determine the efficiency of the follow-up schedule. The Netherlands Cancer Registry provided data of 6,509 women, operated for invasive non-metastatic breast cancer in 2003–2004. In a random sample including 144 patients, adherence to follow-up guideline recommendations was studied. Mode of relapse detection was studied in 124 patients with a second primary breast cancer and 160 patients with a loco regional recurrence. On average 13 visits were performed during the first 5 years of the follow-up, whereas nine were recommended. With one, two and three medical disciplines involved, the number of visits was 9, 14 and 18, respectively. Seventy-five percent (93/124) of patients with a second primary breast cancer, 42 % (31/74) of patients with a loco regional recurrence after breast conserving surgery and 28 % (24/86) of patients with a loco regional recurrence after mastectomy had no symptoms at detection. To detect one loco regional recurrence or second primary breast cancer preclinically, 1,349 physical examinations versus 262 mammography and/or MRI tests were performed. Follow-up provided by only one discipline may decrease the number of unnecessary follow-up visits. Breast imaging plays a major and physical examination a minor role in the early detection of second primary breast cancers and loco regional recurrences. The yield of physical examination to detect relapses early is low and should therefore be minimised.

Keywords

Breast cancer Mammography Physical examination Relapse Routine follow-up 

Notes

Acknowledgments

The authors thank the registrars of the Netherlands Cancer Registry locations Nijmegen, Utrecht, Maastricht and Groningen/Enschede, and the scientific staff and registrars of the Netherlands Cancer Registry for the collection of data. This study was supported by a grant from the Dutch Cancer Society (Grant No. KUN 2008-4086).

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2002) Richtlijn behandeling mammacarcinoomGoogle Scholar
  2. 2.
    Lu WL, Jansen L, Post WJ, Bonnema J, van de Velde CJ, de Bock GH (2009) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 114:403–412PubMedCrossRefGoogle Scholar
  3. 3.
    Houssami N, Ciatto S (2010) Mammographic surveillance in women with a personal history of breast cancer: how accurate? How effective? Breast 19:439–445PubMedCrossRefGoogle Scholar
  4. 4.
    Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P (1999) Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 281:1586PubMedCrossRefGoogle Scholar
  5. 5.
    Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, de Bock GH (2011) Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer 11:279PubMedCrossRefGoogle Scholar
  6. 6.
    Grandjean I, Kwast AB, de Vries H, Klaase J, Schoevers WJ, Siesling S (2011) Evaluation of the adherence to follow-up care guidelines for women with breast cancer. Eur J Oncol Nurs 16(3):281–285PubMedCrossRefGoogle Scholar
  7. 7.
    Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6:174–181PubMedCrossRefGoogle Scholar
  8. 8.
    Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20:1505–1510PubMedCrossRefGoogle Scholar
  9. 9.
    De Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004) Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol 22:4010–4018PubMedCrossRefGoogle Scholar
  10. 10.
    Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2011) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer 47:676–682PubMedCrossRefGoogle Scholar
  11. 11.
    Blamey RW (2002) Estimation of prognosis of the individual with primary breast cancer and its applications. Scand J Surg 91:273–278PubMedGoogle Scholar
  12. 12.
    Hayes DF (2011) An overview of breast cancer. http://www.uptodate.com. Accessed 9 Nov 2011
  13. 13.
    Kwaliteitsinstituut voor de Gezondheidszorg CBO, Nationaal Borstkanker Overleg NABON (2008) MammacarcinomaGoogle Scholar
  14. 14.
    Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafata JE (2006) Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care 44:590–594PubMedCrossRefGoogle Scholar
  15. 15.
    Ciatto S, Miccinesi G, Zappa M (2004) Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer 40:1496–1501PubMedCrossRefGoogle Scholar
  16. 16.
    Montgomery DA, Krupa K, Jack WJ, Kerr GR, Kunkler IH, Thomas J, Dixon JM (2007) Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96:1802–1807PubMedCrossRefGoogle Scholar
  17. 17.
    De Koning HJ, van Dongen JA, van der Maas PJ (1994) Changes in use of breast-conserving therapy in years 1978–2000. Br J Cancer 70:1165–1170PubMedCrossRefGoogle Scholar
  18. 18.
    Voogd AC, van Beek MW, Crommelin MA, Kluck HM, Repelaer van Driel OJ, Coebergh JW (1994) Management of early breast cancer in southeast Netherlands since 1984. A population-based study. Regional Breast Cancer Study Group. Acta Oncol 33:753–757PubMedCrossRefGoogle Scholar
  19. 19.
    Ernst MF, Voogd AC, Coebergh J-WW, Poortmans PM, Roukema JA (2004) Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer 40:487–493PubMedCrossRefGoogle Scholar
  20. 20.
    Van der Heiden-van-der Loo M, Ho VK, Damhuis RA, Siesling S, Menke MB, Peeters PH, Rutgers EJ (2010) Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator. Ned Tijdschr Geneeskd 154:A1984PubMedGoogle Scholar
  21. 21.
    Montgomery DA, Krupa K, Cooke TG (2007) Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 97:1632–1641PubMedCrossRefGoogle Scholar
  22. 22.
    Kwaliteitsinstituut voor de Gezondheidszorg CBO Nationaal Borstkanker Overleg NABON (2012) MammacarcinoomGoogle Scholar
  23. 23.
    Van Hezewijk M, Ranke GMC, van Nes JGH, Stiggelbout AM, de Bock GH, van de Velde CJ (2011) Patients’ needs and preferences in routine follow-up for early breast cancer; an evaluation of the changing role of the nurse practitioner. Eur J Surg Oncol 37:765–773PubMedCrossRefGoogle Scholar
  24. 24.
    Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A (2009) Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 27:6172–6179PubMedCrossRefGoogle Scholar
  25. 25.
    Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, Hupperets P, Nuytinck JK, van Riet Y, Brenninkmeijer SJ, Scheijmans LJ, Kessels A, Lambin P, Boersma LJ (2011) Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer 47:1027–1036PubMedCrossRefGoogle Scholar
  26. 26.
    Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49:705–710PubMedGoogle Scholar
  27. 27.
    Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs 13:2–8PubMedCrossRefGoogle Scholar
  28. 28.
    Brodersen J, Jørgensen KJ, Gøtzsche PC (2010) The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 120:89–94PubMedGoogle Scholar
  29. 29.
    Health Council of the Netherlands (2007) Follow-up in oncology: identify objectives, substantiate actions. Report No. 2007/10. The Hague: Health Council of the NetherlandsGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Sandra M. E. Geurts
    • 1
  • Femmie de Vegt
    • 1
  • Sabine Siesling
    • 2
    • 3
  • Karin Flobbe
    • 2
  • Katja K. H. Aben
    • 1
    • 2
  • Margriet van der Heiden-van der Loo
    • 2
  • André L. M. Verbeek
    • 1
  • Jos A. A. M. van Dijck
    • 1
  • Vivianne C. G. Tjan-Heijnen
    • 4
  1. 1.Department of Epidemiology, Biostatistics and HTARadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  2. 2.Comprehensive Cancer Centre the NetherlandsUtrechtThe Netherlands
  3. 3.Health Technology and Services ResearchTwente UniversityEnschedeThe Netherlands
  4. 4.Department of Internal Medicine, GROW – School for Oncology and Developmental Biology, Division of Medical OncologyMaastricht University Medical CentreMaastrichtThe Netherlands

Personalised recommendations